Technical Analysis for BRRGF - BerGenBio ASA

Grade Last Price % Change Price Change
grade C 1.6 -60.77% -2.4780
BRRGF closed down 60.77 percent on Thursday, June 20, 2019, on 8 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical BRRGF trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
New Downtrend Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%

Older signals for BRRGF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
BerGenBio ASA, a clinical stage oncology biotech company, develops medicines to treat cancer. Its lead candidate is BGB324, a bioavailable small molecule AXL inhibitor, which is in Phase II clinical development in two major cancer indications. The Phase II clinical trial programme focuses on non-small lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as melanoma and triple negative breast cancer. In addition, it is developing BGB149, a function blocking antibody with potent pre-clinical anti-tumor activity; and BGB601, an antibody drug conjugate against human AXL that is linked to a cytotoxin. ASA has a collaboration agreement with Merck & Co.for clinical trials. BerGenBio ASA was founded in 2007 and is headquartered in Bergen, Norway.
Medicine Cancer Clinical Medicine Chemotherapy Immune System Cancer Treatments Melanoma Antineoplastic Drugs Myelodysplastic Syndrome Pyrrolidines Triple Negative Breast Cancer Bemcentinib Protein Kinase Inhibitors
Is BRRGF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 4.15
52 Week Low 1.2665
Average Volume 6,538
200-Day Moving Average 0.0
50-Day Moving Average 2.181
20-Day Moving Average 2.4665
10-Day Moving Average 2.9219
Average True Range 0.3242
ADX 30.41
+DI 38.3811
-DI 60.5533
Chandelier Exit (Long, 3 ATRs ) 3.1774
Chandelier Exit (Short, 3 ATRs ) 2.5726
Upper Bollinger Band 4.1457
Lower Bollinger Band 0.7873
Percent B (%b) 0.24
BandWidth 136.160551
MACD Line 0.3386
MACD Signal Line 0.2741
MACD Histogram 0.0645
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.6000
Resistance 3 (R3) 1.6000 1.6000 1.6000
Resistance 2 (R2) 1.6000 1.6000 1.6000 1.6000
Resistance 1 (R1) 1.6000 1.6000 1.6000 1.6000 1.6000
Pivot Point 1.6000 1.6000 1.6000 1.6000 1.6000
Support 1 (S1) 1.6000 1.6000 1.6000 1.6000 1.6000
Support 2 (S2) 1.6000 1.6000 1.6000 1.6000
Support 3 (S3) 1.6000 1.6000 1.6000
Support 4 (S4) 1.6000